Literature DB >> 23099270

Safety of growth hormone treatment in patients previously treated for cancer.

Wassim Chemaitilly1, Leslie L Robison.   

Abstract

This review provides an overview of the safety of growth hormone replacement therapy in individuals previously treated for cancer. The review focuses on the risk of disease recurrence and second neoplasm occurrence with special attention to data on childhood cancer survivors.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23099270     DOI： 10.1016/j.ecl.2012.07.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  6 in total

1.  Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes.

Authors:  Wassim Chemaitilly; Thomas E Merchant; Zhenghong Li; Nicole Barnes; Gregory T Armstrong; Kirsten K Ness; Ching-Hon Pui; Larry E Kun; Leslie L Robison; Melissa M Hudson; Charles A Sklar; Amar Gajjar
Journal:  Clin Endocrinol (Oxf)       Date:  2015-11-16       Impact factor: 3.478

2.  Modifiable Factors Associated With Aging Phenotypes Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia.

Authors:  Carmen L Wilson; Wassim Chemaitilly; Kendra E Jones; Sue C Kaste; Deo Kumar Srivastava; Rohit P Ojha; Yutaka Yasui; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  J Clin Oncol       Date:  2016-03-21       Impact factor: 44.544

3.  Occurrence of Cranial Neoplasms in Pediatric Patients with Noonan Syndrome Receiving Growth Hormone: Is Screening with Brain MRI prior to Initiation of Growth Hormone Indicated?

Authors:  Kanthi Bangalore Krishna; Pedro Pagan; Oscar Escobar; Jadranka Popovic
Journal:  Horm Res Paediatr       Date:  2017-07-26       Impact factor: 4.275

Review 4.  Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports.

Authors:  Judith U Cope; Gregory H Reaman; Joseph M Tonning
Journal:  Sarcoma       Date:  2015-05-07

Review 5.  Endocrinopathies in survivors of childhood neoplasia.

Authors:  Nicole Barnes; Wassim Chemaitilly
Journal:  Front Pediatr       Date:  2014-09-23       Impact factor: 3.418

Review 6.  Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice.

Authors:  Margaret C S Boguszewski; Adriane A Cardoso-Demartini; Cesar Luiz Boguszewski; Wassim Chemaitilly; Claire E Higham; Gudmundur Johannsson; Kevin C J Yuen
Journal:  Pituitary       Date:  2021-07-25       Impact factor: 4.107
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.